PortfoliosLab logoPortfoliosLab logo
ISIN
US40145W1018
IPO Date
Sep 26, 2024

Highlights

Market Cap
$2.48B
Enterprise Value
$2.43B
EPS (TTM)
$0.84
PE Ratio
46.56
PEG Ratio
1.12
Total Revenue (TTM)
$1.46B
Gross Profit (TTM)
$294.00M
EBITDA (TTM)
$101.87M
Year Range
$19.17 - $41.36
Target Price
$38.00
ROA (TTM)
12.43%
ROE (TTM)
22.83%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Guardian Pharmacy Services, Inc

Performance

GRDN Performance Chart

Guardian Pharmacy Services, Inc (GRDN) is up 29.4% since the beginning of the year. At $39 per share, GRDN is trading 5.9% below its 52-week high of $41.


Loading charts...

S&P 500 Index

Returns By Period

Guardian Pharmacy Services, Inc (GRDN) has returned 29.35% so far this year and 82.81% over the past 12 months.


Guardian Pharmacy Services, Inc

1D
-0.87%
1M
4.15%
YTD
29.35%
6M
32.92%
1Y
82.81%
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

GRDN Monthly Returns History

Based on dividend-adjusted daily data since Sep 26, 2024, GRDN's average daily return is +0.26%, while the average monthly return is +4.85%. At this rate, an investment would double in approximately 1.2 years.

Historically, 73% of months were positive and 27% were negative. The best month was Nov 2024 with a return of +39.3%, while the worst month was Dec 2024 at -18.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 1 months.

On a daily basis, GRDN closed higher 54% of trading days. The best single day was Aug 12, 2025 with a return of +13.8%, while the worst single day was May 21, 2025 at -16.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20260.37%10.96%12.38%-1.49%4.42%0.46%29.35%
202512.59%-12.32%6.30%17.78%-15.46%0.66%-1.92%26.41%-0.72%6.90%4.42%2.77%48.52%
20245.00%6.61%39.25%-18.77%26.63%

Benchmark Metrics

Guardian Pharmacy Services, Inc has an annualized alpha of 65.33%, beta of 0.79, and R2 of 0.08 versus S&P 500 Index. Calculated based on daily prices since September 27, 2024.

  • This stock captured 167.75% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -147.11%) - a profile typical of hedging or uncorrelated assets.
  • R2 of 0.08 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
65.33%
Beta
0.79
0.08
Upside Capture
167.75%
Downside Capture
-147.11%

Return for Risk

Risk / Return Rank

GRDN ranks 86 for risk / return — in the top 86% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


GRDN Risk / Return Rank: 8686
Overall Rank
GRDN Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
GRDN Sortino Ratio Rank: 8484
Sortino Ratio Rank
GRDN Omega Ratio Rank: 8383
Omega Ratio Rank
GRDN Calmar Ratio Rank: 8585
Calmar Ratio Rank
GRDN Martin Ratio Rank: 8787
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Guardian Pharmacy Services, Inc (GRDN) and compare them to S&P 500 Index.


GRDNBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

2.07

2.39

-0.32

Sortino ratio

Return per unit of downside risk

2.70

3.25

-0.55

Omega ratio

Gain probability vs. loss probability

1.34

1.43

-0.09

Calmar ratio

Return relative to maximum drawdown

3.66

3.11

+0.55

Martin ratio

Return relative to average drawdown

10.55

14.38

-3.84

Dividends

Dividend History


Guardian Pharmacy Services, Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Guardian Pharmacy Services, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Guardian Pharmacy Services, Inc was 27.21%, occurring on Mar 6, 2025. Recovery took 40 trading sessions.

The current Guardian Pharmacy Services, Inc drawdown is 4.26%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-27.21%Mar 2025
2mo 23d1mo 27d
4mo 20dDec 2024 - May 2025
2025 selloff2025
-25.83%Jun 2025
28d2mo 17d
3mo 15dMay 2025 - Sep 2025
2025 bear market2025
-22.74%Oct 2025
28d1mo 2d
2moSep 2025 - Nov 2025
2026 correction2026
-14.33%Jan 2026
2mo 4d17d
2mo 21dNov 2025 - Feb 2026
2026 correction2026
-14.12%May 2026
1mo 2d
1mo 25dApr 2026 - now

Drawdown Indicators


GRDNBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-27.21%

-56.78%

+29.57%

Max Drawdown (1Y)

Largest decline over 1 year

-22.74%

-9.10%

-13.64%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-4.26%

0.00%

-4.26%

Average Drawdown

Average peak-to-trough decline

-9.91%

-10.72%

+0.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.88%

1.97%

+5.91%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Guardian Pharmacy Services, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Guardian Pharmacy Services, Inc is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for GRDN, comparing it with other companies in the Medical Care Facilities industry. Currently, GRDN has a P/E ratio of 46.6. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for GRDN compared to other companies in the Medical Care Facilities industry. GRDN currently has a PEG ratio of 1.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for GRDN relative to other companies in the Medical Care Facilities industry. Currently, GRDN has a P/S ratio of 1.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for GRDN in comparison with other companies in the Medical Care Facilities industry. Currently, GRDN has a P/B value of 10.7. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with GRDN

Add Guardian Pharmacy Services, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with GRDN